G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $695,000 | -34.7% | 46,900 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,065,000 | -0.8% | 46,900 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,074,000 | +27.1% | 46,900 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $845,000 | +463.3% | 46,900 | +263.6% | 0.00% | +200.0% |
| Q3 2020 | $150,000 | -74.4% | 12,900 | -31.4% | 0.00% | -66.7% |
| Q2 2019 | $585,000 | -15.3% | 18,800 | +63.5% | 0.00% | -25.0% |
| Q1 2019 | $691,000 | +283.9% | 11,500 | +22.3% | 0.00% | +300.0% |
| Q4 2018 | $180,000 | -74.0% | 9,400 | -18.3% | 0.00% | -75.0% |
| Q3 2018 | $691,000 | +37.1% | 11,500 | -2.5% | 0.00% | +33.3% |
| Q2 2018 | $504,000 | +19.1% | 11,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $423,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |